IPO Trending
JFLLIFESME / NSEListed

JFL Life Sciences Limited

JFL Life Sciences Limited, established in 2010, is a pharmaceutical company specializing in the manufacturing of a variety of medicines. Its product range includes dry powder injections (B-Lactam), tablets, capsules (B-Lactam and general), and oral rehydration solutions (ORS). The company follows a bulk sales strategy, supplying its products to pharmaceutical marketers and traders who then distribute them to customers. JFL has a strong presence across India and exports to 10 countries worldwide. Internationally, JFL supplies products to African, Middle Eastern, and CIS countries through merchant exporters. The company is also registered with the Ministries of Health (MOH) in Kenya, Nigeria, Yemen, Cambodia, and Myanmar for specific products, with additional registrations in Ukraine, Uzbekistan, and Kazakhstan. JFL operates two leased manufacturing units in Gujarat to produce its pharmaceutical products.

₹61 - ₹618.93x sub
GMPFlat
Est. Listing Price₹61
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Aug-19)3177.96 Cr
Growth+24.0%
Revenue Trend (₹ in Crores)
0.01.3k2.5k3.8kFeb-22Mar-21Mar-20Aug-19
PeriodRev (Cr)PAT (Cr)AssetsDebt
Aug-193177.9630.251614.960
Mar-203020.4136.042432.590
Mar-213286.8954.212900.690
Feb-222563.06253.283662.860